Wednesday, February 21, 2007
U.S. Congress Probes Possible Drug Maker Pricing "Fraud"
A U.S. Congressional Committee is investigating claims of “waste, fraud and abuse in pharmaceutical pricing,” which allege that some drug manufacturers are profiteering from public health programs, according to PharmaTimes World News.
“If even half of the allegations involving the pharmaceutical industry are true, billions of federal dollars that should be buying needed care are instead adding to drug company profits,” said Democratic Representative Henry Waxman, chairman of the House Committee on Oversight and Government Reform, which has just held a hearing on the issue, reported the PharmaTimes.
The hearing was told that drug makers have been defrauding Medicaid, according to whistleblowers who have filed dozens of cases over the last decade, drug manufacturers have deliberately crafted business plans to avoid giving Medicaid the proper discounts,” said Rep Waxman.
Click here to learn more about the Congressional Committee’s aggressive oversight agenda.
Posted by Quitam Help Admin on 02/21 at 06:02 PM
Page 1 of 1 pages
Printer Friendly Page